Protection of Man from Natural Infection with Influenza A2 Hong Kong Virus by Amantadine: A Controlled Field Trial

Oker-Blom, N.; Hovi, T.; Leinikki, P.; Palosuo, T.; Pettersson, R.; Suni, J.
September 1970
British Medical Journal;9/19/1970, Vol. 3 Issue 5724, p676
Academic Journal
No abstract available.


Related Articles

  • Influenza.  // Weekly Epidemiological Record;9/8/2000, Vol. 75 Issue 36, p296 

    Reports the infected areas due to influenza outbreak. Growth in the influenza activity in Australia; Existence of influenza A virus as the predominant type; Isolation of influenza viruses from Hong Kong.

  • Update: Isolation of avian influenza A (H5N1) viruses from humans--Hong Kong, 1997-1998. Saw, T.A.; Lim, W. // MMWR: Morbidity & Mortality Weekly Report;1/9/1998, Vol. 46 Issue 52/53, p1245 

    Presents information from the findings of an epidemiologic and laboratory investigation conducted by the Center for Disease Control (CDC) on the avian influenza A(H5N1) viruses in Hong Kong. Identification of the number of case as of January 6, 1998; Details on the first known case of human...

  • Structure of avian flu virus confirmed. Wise, Jacqui // BMJ: British Medical Journal (International Edition);01/24/98, Vol. 316 Issue 7127, p249 

    Reports that a team of researchers from the Centers for Disease Control and Prevention in Atlanta, Georgia, has confirmed the molecular structure of the avian influenza virus present in Hong Kong. Identification of the virus; Human infection from the virus; Transfer of the virus between humans.

  • Outbreak of Avian Influenza A(H5N1) Virus Infection in Hong Kong in 1997. Chan, Paul K.S. // Clinical Infectious Diseases;5/1/2002 Supplement 2, Vol. 34, pS58 

    Presents information on the outbreak of avian influenza A virus infection in Hong Kong, China in 1997. Epidemiology of the infection; Clinical manifestations of the infection; Pathology of the infection; Approaches to control the infection.

  • Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain. Skowronski, Danuta M.; Janjua, Naveed Z.; Hottes, Travis S.; De Serres, Gaston // Clinical Infectious Diseases;Mar2011, Vol. 52 Issue 6, p831 

    A letter to the editor is presented in response to the article "Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong" by B.J. Cowling and colleagues in a 2010 issue.

  • Avian influenza. JH // CMAJ: Canadian Medical Association Journal;02/10/98, Vol. 158 Issue 3, p369 

    Focuses on the first documented case of human infection with avian influenza A(H5N1) virus. The expansion of influenza surveillance in Hong Kong since December 1997; How there could be an influenza pandemic; Sensitivity of A(H5N1) to amantadine and rimantadine; The types of influenza strains...

  • Characterization of the amantadine-resistant H5N1 highly pathogenic avian influenza variants isolated from quails in Southern China. Dong, Guoying; Luo, Jing; Zhou, Kai; Wu, Bin; Peng, Chao; Ji, Guangju; He, Hongxuan // Virus Genes;Oct2014, Vol. 49 Issue 2, p223 

    Highly pathogenic H5N1 avian influenza viruses have spread in poultry and wild birds in Asia, Europe, and Africa since 2003. To evaluate the role of quails in the evolution of influenza A virus, we characterized three H5N1 viruses isolated from quails (QA viruses) in southern China. Phylogenetic...

  • Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1). Cheng, Peter K. C.; Leung, Tommy W. C.; Ho, Eric C. M.; Leung, Peter C. K.; Ng, Anita Y. Y.; Lai, Mary Y. Y.; Lim, Wilina W. L. // Emerging Infectious Diseases;Jun2009, Vol. 15 Issue 6, p966 

    Surveillance of amantadine and oseltamivir resistance among influenza viruses was begun in Hong Kong in 2006. In 2008, while both A/Brisbane/59/2007-like and A/Hong Kong/2652/2006-like viruses (H1N1) were cocirculating, we detected amantadine and oseltamivir resistance among A/Hong...

  • Influenza.  // Weekly Epidemiological Record;5/31/2002, Vol. 77 Issue 22, p183 

    Reports on influenza virus infection outbreaks in Australia, Hong Kong, New Caledonia and Paraguay as of May 2002.

  • Management of Influenza: Use of New Antivirals and Resistance in Perspective. Jackson, H.C.; Roberts, N.; Wang, Z.M.; Belshe, R. // Clinical Drug Investigation;2000, Vol. 20 Issue 6, p447 

    In most years epidemics of influenza cause a significant increase in morbidity and mortality worldwide. With the availability of a new class of antivirals targeting the viral protein neuraminidase, there are new options for the control of influenza. The use of the older antiviral agents (M2...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics